Viking Therapeutics to Report Financial Results for Third Quarter 2026 on October 28, 2026
PR Newswire•21/10/2026•16:05 ET
0
Key Highlights
- ➤Viking Therapeutics (VKTX) will report Q3 2026 financial results October 28 after market close
- ➤Conference call scheduled for October 28 at 4:30 p.m. Eastern Time
- ➤VK2735 is in Phase 3 studies for obesity in subcutaneous and oral formulations
- ➤VK3019, VK2809, and VK0214 represent additional obesity, metabolic, and rare-disease programs
Viking Therapeutics to Report Financial Results for Third Quarter 2026 on October 28, 2026 PR Newswire
Conference Call Scheduled for Wednesday, October 28, at 4:30 p.m. Eastern Time
Get started
Create a free account to read the full story.